|Sponsor||Summit Corporation plc|
This is a randomised double-blind placebo control study of the drug SMT C11003.
Boys will be put in three different treatment sequence groups. Each patient will receive two doses of the drug (increased amounts per dose) with a placebo also being used. The length of each study depends on which treatment the patient will receive.
To find out the required dose of the drug in patients
with a balanced diet.